Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.
Apolipoprotein E (ApoE) is a potent risk factor for Alzheimer's disease. Since the loss of cholinergic function in Alzheimer's disease is known to occur at an early stage in the disease we have examined this function in normal subjects with an Apoepsilon4 allele to see if the deficit occur...
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
1997
|
| _version_ | 1826295247621062656 |
|---|---|
| author | Allen, S MacGowan, S Tyler, S Wilcock, G Robertson, A Holden, P Smith, S Dawbarn, D |
| author_facet | Allen, S MacGowan, S Tyler, S Wilcock, G Robertson, A Holden, P Smith, S Dawbarn, D |
| author_sort | Allen, S |
| collection | OXFORD |
| description | Apolipoprotein E (ApoE) is a potent risk factor for Alzheimer's disease. Since the loss of cholinergic function in Alzheimer's disease is known to occur at an early stage in the disease we have examined this function in normal subjects with an Apoepsilon4 allele to see if the deficit occurs in the absence of Alzheimer pathology or symptoms. We report that brain tissue obtained post-mortem from normal subjects and Alzheimer patients with an Apoepsilon4 allele has a lower cholinergic activity than tissue from those subjects without this allele. This has important significance for the interpretation of the cholinergic deficits found in Alzheimer's disease. |
| first_indexed | 2024-03-07T03:58:06Z |
| format | Journal article |
| id | oxford-uuid:c38fcfdb-f839-4f53-b09c-269f5aaeb185 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T03:58:06Z |
| publishDate | 1997 |
| record_format | dspace |
| spelling | oxford-uuid:c38fcfdb-f839-4f53-b09c-269f5aaeb1852022-03-27T06:17:24ZReduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c38fcfdb-f839-4f53-b09c-269f5aaeb185EnglishSymplectic Elements at Oxford1997Allen, SMacGowan, STyler, SWilcock, GRobertson, AHolden, PSmith, SDawbarn, DApolipoprotein E (ApoE) is a potent risk factor for Alzheimer's disease. Since the loss of cholinergic function in Alzheimer's disease is known to occur at an early stage in the disease we have examined this function in normal subjects with an Apoepsilon4 allele to see if the deficit occurs in the absence of Alzheimer pathology or symptoms. We report that brain tissue obtained post-mortem from normal subjects and Alzheimer patients with an Apoepsilon4 allele has a lower cholinergic activity than tissue from those subjects without this allele. This has important significance for the interpretation of the cholinergic deficits found in Alzheimer's disease. |
| spellingShingle | Allen, S MacGowan, S Tyler, S Wilcock, G Robertson, A Holden, P Smith, S Dawbarn, D Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. |
| title | Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. |
| title_full | Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. |
| title_fullStr | Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. |
| title_full_unstemmed | Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. |
| title_short | Reduced cholinergic function in normal and Alzheimer's disease brain is associated with apolipoprotein E4 genotype. |
| title_sort | reduced cholinergic function in normal and alzheimer s disease brain is associated with apolipoprotein e4 genotype |
| work_keys_str_mv | AT allens reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype AT macgowans reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype AT tylers reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype AT wilcockg reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype AT robertsona reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype AT holdenp reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype AT smiths reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype AT dawbarnd reducedcholinergicfunctioninnormalandalzheimersdiseasebrainisassociatedwithapolipoproteine4genotype |